Business Wire

Mavenir Proves AMD Technology across its Open RAN OpenBeam™ Radio and Converged Packet Core Portfolio

1.2.2023 17:00:00 EET | Business Wire | Press release

Share

Mavenir, the Network Software Provider building the future of networks with cloud-native software that runs on any cloud, today announced new initiatives in collaboration with AMD to help Communication Service Providers (CSPs) in their transition to cloud-native telecommunication networks.

First, Mavenir and AMD have been collaborating in Open RAN to build industry leading radio technology. Mavenir has incorporated the AMD Zynq™ Ultrascale+™ RFSoC devices into Mavenir’s OpenBeam™ Radio Portfolio and, through this partnership, both companies continue to work together to introduce new functionality, features, and capabilities to customers.

Secondly, Mavenir’s Converged Packet Core has been validated on AMD EPYC™ CPUs – This means Mavenir’s cloud-native, fully containerized, virtualized Converged Packet Core (4G & 5G) solution can now be deployed on AMD EPYC server CPUs to provide CSPs with more options to implement virtual network functions in cloud data centers.

The elements validated include AMF, SMF, UPF, UDSF, NRF, NSSF, AUSF, UDM, and UDR network functions. Additionally, PCF, NEF, BSF, MME, SecGw, PCRF, MME and SGSN network functions will be validated in the coming months.

“Mavenir’s commitment to enabling networks built on software that runs on any cloud revolves around giving CSPs the ability to use the best components that fit their specific needs, in the cell-site and in the data center,” said Bejoy Pankajakshan, EVP, Chief Technology and Strategy Officer, Mavenir. “Mavenir and AMD are working together to give CSPs multiple options and help them optimize power consumption, network efficiency and total cost of ownership in the radio access as well as the core network.”

“Cloud-native telecom networks empower CSPs with systems that offer flexibility, lower operational cost, ease of system management, and a broader ecosystem for value add, innovation, and upgrade capabilities as network requirements grow,” said Salil Raje, senior vice president and general manager, Data Center and Communications Group, AMD. “We are extremely proud of our close collaboration with Mavenir to help deliver exceptional TCO and predictable scalability along with high performance and power efficient solutions to telecommunications operators leveraging AMD data center products.”

Mavenir’s OpenBeam innovative radio portfolio is specifically designed for the growing needs of CSPs with agile, cost-efficient, intelligent radios to meet critical demands on the network now, and as the network changes and expands. The radio solutions can be used for a wide range of use cases, including basic coverage across all frequency bands, outdoor small cells, for public and private networks providing business and consumer services in both urban and rural environments.

Mavenir’s Converged Packet Core is an end-to-end, fully containerized portfolio that offers multi-generational support to modernize existing mobile networks while providing a cost-effective journey to 5G. Its cloud-native architecture, with applications and services purpose-built for the cloud model, offers easy scaling, hardware decoupling, agility, portability and resiliency across public, private and hybrid clouds. Its web-scale granular microservice architecture meets carrier-grade requirements such as high availability, security, and performance.

To know more about the joint collaboration, visit Mavenir (hall 2 stand 2H60) and AMD (hall 2 stand 2M61) at Mobile World Congress 2023 in Barcelona (February 27th – March 2nd).

AMD, the AMD Arrow logo, EPYC™, Zynq™ and Ultrascale+™, and combinations thereof, are trademarks of Advanced Micro Devices, Inc. Other names are for informational purposes only and may be trademarks of their respective owners.

About Mavenir:

Mavenir is building the future of networks and pioneering advanced technology, focusing on the vision of a single, software-based automated network that runs on any cloud. As the industry's only end-to-end, cloud-native network software provider, Mavenir is focused on transforming the way the world connects, accelerating software network transformation for 250+ Communications Service Providers and Enterprises in over 120 countries, which serve more than 50% of the world's subscribers. www.mavenir.com

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

PR Contact:
PR@mavenir.com

Maryvonne Tubb (US)
Emmanuela Spiteri (EMEA)

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

IQM Secures €50M Financing to Accelerate Global Growth30.3.2026 09:00:00 EEST | Press release

IQM Finland Oy, a global leader in full-stack superconducting quantum computers (“IQM”, “IQM Quantum Computers” or the “Company”), today announced it has secured a €50 millionfinancing package from funds and accounts managed by BlackRock. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260329996942/en/ IQM Radiance quantum computer is located in IQM's showroom in Espoo, Finland. This facility will support acceleration of IQM’s technology roadmap, fuel R&D, support entry into additional markets, and advance IQM’s leadership in quantum computing. This facility was secured prior to IQM’s recent announcement of plans to become the first publicly listed European quantum computing company through a merger with Real Asset Acquisition Corp (“RAAQ”). The facility lowers IQM’s overall cost of capital and improves the flexibility and diversity of its capital base. “The financing package comes at a pivotal time for IQM, as we build momen

Bureau Veritas and Trade Technologies Join Forces to Streamline Global Trade Operations30.3.2026 08:45:00 EEST | Press release

Bureau Veritas, a global leader in Testing, Inspection, and Certification services (TIC), through its Swiss branch Government Services Division, is pleased to announce a strategic agreement with Trade Technologies, the leading provider of trade finance automation, connectivity and transaction management services. This collaboration is a significant step toward reducing the complexities of international trade operations, particularly in regions where regulatory and inspection controls remain stringent. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260329411683/en/ Addressing Critical Trade Finance Challenges The agreement comes at a pivotal time for global trade. Letters of Credit (LCs) continue to serve as essential instruments in international commerce, particularly across the Middle East and Africa, where counterparty risk, foreign exchange controls, sanctions exposure, and regulatory oversight face ongoing challenges. In

Consortium Led by Axelspace Selected for Japan’s Space Strategy Fund Project “Technology to Enhance Capability of Next Generation Earth Observation Satellites”30.3.2026 02:35:00 EEST | Press release

Axelspace Corporation, Meisei Electric Co., Ltd., ANA HOLDINGS INC., and JIJ Inc. are pleased to announce that their jointly proposed technology development project has been selected for Japan Aerospace Exploration Agency (JAXA)’s Space Strategy Fund under the theme “Technology to Enhance Capability of Next Generation Earth Observation Satellites.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260323044518/en/ Conceptual Diagram of the project. Under this Space Strategy Fund initiative, spectrometers will be newly developed and demonstrated in orbit. In the future, the project envisions the establishment of a satellite constellation capable of observations at different times of the day. Project Summary (Planned) Technology Development Theme: Technology to Enhance Capability of Next Generation Earth Observation Satellites Project Title: Source-Specific CO2 Emission and Uptake Monitoring through Satellite Constellation and Ai

Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 21:00:00 EET | Press release

Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham, MSc, MD, FRCPC, dermatologist, SKiN Centre for Dermatology, Peterborough, Ontario, Canada, principal investigator for the Latitude PsO studies and presenting author. “These efficacy and safety results show it’s possible for a once-daily pill to deliver rapid, lasting skin clearance, highlighting the potential of zasoc

Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 21:00:00 EET | Press release

Incyte (Nasdaq:INCY) today announced 54-week data evaluating the safety and efficacy of povorcitinib (INCB54707), an oral small-molecule highly-selective JAK1 inhibitor, from the pivotal Phase 3 STOP-HS clinical trial program in adult patients (≥18 years) with moderate to severe hidradenitis suppurativa (HS). The late-breaking oral presentation of these data is taking place at the 2026 American Academy of Dermatology (AAD) Annual Meeting, being held March 27-31, 2026, in Denver (Session: S034 – Late-Breaking Research: Session 2. Saturday, March 28, 2026, 1:00-4:00 p.m. MT). “The 54-week results from the STOP-HS program deliver compelling, long-term evidence supporting the potential of povorcitinib for patients with moderate to severe HS,” said Pablo J. Cagnoni, M.D., President and Global Head of Research and Development, Incyte. “Across both studies, povorcitinib demonstrated substantial and durable improvements over time in key measures of treatment success and meaningful clinical ben

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye